Adam Ron
Stock Analyst at B of A Securities
(2.26)
# 2,718
Out of 5,138 analysts
15
Total ratings
54.55%
Success rate
11.7%
Average return
Main Sectors:
Stocks Rated by Adam Ron
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALHC Alignment Healthcare | Maintains: Buy | $16 → $19 | $22.50 | -17.78% | 1 | Mar 4, 2025 | |
| ASTH Astrana Health | Maintains: Buy | $55 → $49 | $27.40 | +78.83% | 1 | Mar 4, 2025 | |
| OSCR Oscar Health | Downgrades: Underperform | $21 → $14 | $17.42 | -22.50% | 11 | Nov 6, 2024 | |
| PRVA Privia Health Group | Downgrades: Neutral | $27 → $21 | $23.86 | -11.99% | 2 | Feb 22, 2024 |
Alignment Healthcare
Mar 4, 2025
Maintains: Buy
Price Target: $16 → $19
Current: $22.50
Upside: -17.78%
Astrana Health
Mar 4, 2025
Maintains: Buy
Price Target: $55 → $49
Current: $27.40
Upside: +78.83%
Oscar Health
Nov 6, 2024
Downgrades: Underperform
Price Target: $21 → $14
Current: $17.42
Upside: -22.50%
Privia Health Group
Feb 22, 2024
Downgrades: Neutral
Price Target: $27 → $21
Current: $23.86
Upside: -11.99%